Novavax (NVAX) Tops Q4 EPS by 9c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $7.97 -2.92%
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
DIT, AMC, DPZ, More
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.51), $0.09 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $88.31 million versus the consensus estimate of $102.74 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Iran Will Pay For US Forces Killings Many Times Over
- Pershing Square Holdings (PSHD) Declares $0.1837 Quarterly Dividend; 0% Yield
- Ed Miliband appointed UK's new Foreign Secretary
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
